This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
A bill has been introduced into the Ohio Legislature to prohibit the manufacture and sale of proprietary medicines in the State. Should the bill pass a fine of from $500 to $5,000 will be laid on the manufacturer of such medicines, and their sale will be punished by a fine of from $100 to $300. In several other States than Ohio the question of the manufacture and sale of proprietary medicines is being agitated, and efforts being made to lessen the evils that undoubtedly arise from the indiscreet and indiscriminate use of the proprietary compounds that take up the larger part of the shelf-room in our drug-stores. Whether the bill before the Ohio Legislature is Constitutional or not we will not pretend to say. A less drastic measure, and one that, it appears, would meet with less opposition, would be the adoption of the French method of dealing with this
REGULATING THE SALE OF PROPRIETARY MEDICINES. JAMA. 1889;XII(13):453–454. doi:10.1001/jama.1889.02400900021007
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: